Cogent Biosciences, Inc. (COGT) vs Waystar Holding Corp. (WAY)

A side-by-side comparison of Cogent Biosciences, Inc. and Waystar Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COGT vs WAY

growth of $100 · dividends reinvested · last 2y
COGT +267.1% (+91.6%/yr)WAY +27.9% (+13.1%/yr)COGT compounded faster over this window
100200300400500Start $10020252026$367$128
COGT WAY

COGT vs WAY: by the numbers

  • •COGT is the larger company ($5.15B vs $5.00B market cap).
  • •WAY is profitable (11.18% net margin) while COGT runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCOGTWAY
P/E ratioN/A37.25
Forward P/EN/A15.62
P/S ratioN/A4.15
P/B ratio11.011.25
EV / EBITDAN/A14.96
FCF yieldN/A4.93%

Profitability

MetricCOGTWAY
Gross margin0.00%69.11%
Operating margin0.00%22.87%
Net margin0.00%11.18%
ROE-70.85%3.38%
ROIC-50.09%3.38%

Growth (annualized)

MetricCOGTWAY
Total return CAGR (5Y)28.51%N/A

Frequently asked

Is COGT or WAY more profitable?
WAY runs the higher net margin — COGT at 0.00% versus WAY at 11.18%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.